Senator John Fetterman revealed Tuesday in a piece he penned in The New York Times that he has been using the popular weight ...

Bryan Johnson, the anti-aging influencer, halted his Rapamycin regimen after five years due to adverse side effects like ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Dr. Evan Levine tackles a drug that is often prescribed to help children perform better — a phenomenon he calls “borderline ...

The Trump administration announced that it will not expand coverage for weight loss medication, GLP-1 drugs like Zepbound and ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug ...

Ketamine, a Class B drug, is a dissociative anaesthetic which is often used as a party drug but can cause serious health ...

A new study shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less effective.